We are live on
!
Find out more
Milestone Pharmaceuticals
MIST
MIST
39 hedge funds and large institutions have $60.7M invested in Milestone Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 14 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
107% more call options, than puts
Call options by funds: $601K | Put options by funds: $290K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
3% more capital invested
Capital invested by funds: $59M → $60.7M (+$1.71M)
3.38% less ownership
Funds ownership: 62.01% → 58.63% (-3.4%)
19% less funds holding
Funds holding: 48 → 39 (-9)
36% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 14
82% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 11
Holders
39
Holders Change
-9
Holders Change %
-18.75%
% of All Funds
0.62%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
2
Increased
9
Reduced
14
Closed
11
Calls
$601K
Puts
$290K
Net Calls
+$311K
Net Calls Change
+$328K
Top Buyers
| 1 |
AFA
Alta Fundamental Advisers
New York
|
+$865K |
| 2 |
BlackRock
New York
|
+$403K |
| 3 |
AAA
Affinity Asset Advisors
New York
|
+$109K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$19.2K |
| 5 |
Goldman Sachs
New York
|
+$10.7K |
Top Sellers
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$1.21M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$663K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$539K |
| 4 |
Barclays
London,
United Kingdom
|
-$483K |
| 5 |
Morgan Stanley
New York
|
-$325K |
